Trident Lifeline's Stake in Subsidiary Trident Mediquip Reduces to 59.47% After Private Placement

1 min read     Updated on 17 Apr 2026, 05:53 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Trident Lifeline Limited's shareholding in subsidiary Trident Mediquip Limited decreased to 59.47% from 59.77% following a private placement of equity shares to other shareholders. Trident Mediquip Limited, operating in the pharmaceuticals industry, has a paid-up share capital of Rs. 9,86,58,000 and reported a turnover of 21.29 crore. The transaction was conducted on an arm's length basis and involved related party considerations due to common promoter group interests.

powered bylight_fuzz_icon
37974204

*this image is generated using AI for illustrative purposes only.

Trident Lifeline Limited has informed the stock exchanges about a change in its subsidiary shareholding structure following a private placement transaction by Trident Mediquip Limited. The disclosure was made under Regulation 30 of SEBI (LODR) Regulations, 2015 on April 17, 2026.

Shareholding Change Details

The company's stake in its subsidiary Trident Mediquip Limited has been reduced due to the private placement of equity shares to other shareholders. The shareholding change reflects a dilution in the parent company's ownership percentage.

Parameter: Details
Pre-holding: 59.77%
Post-holding: 59.47%
Transaction Type: Private Placement
Date of Disclosure: April 17, 2026

About Trident Mediquip Limited

Trident Mediquip Limited (CIN: U33309GJ2019PLC110421) is a subsidiary company incorporated under the Companies Act, 2013, with its registered office in Surat, Gujarat. The company operates in the pharmaceuticals and chemical industry.

Financial Details: Amount/Quantity
Authorized Share Capital: Rs. 10,00,00,000
Paid-up Share Capital: Rs. 9,86,58,000
Number of Equity Shares: 98,65,800 shares
Face Value per Share: Rs. 10
Current Turnover: 21.29 Cr

Historical Performance

The subsidiary has shown varying performance over the past three years in terms of turnover:

Financial Year: Turnover
2022-23: 28.77 Cr
2023-24: 20.58 Cr
2024-25: 21.29 Cr

Related Party Transaction

The transaction qualifies as a related party transaction since Trident Mediquip Limited is a subsidiary of Trident Lifeline Limited. Several promoter group members, including Mr. Amit Bhupendra Halvawala, Mr. Chetan Chandrakant Jariwala, and Mr. Hardik Jigishkumar Desai, have interests in both entities. The company has confirmed that the transaction was conducted on an arm's length basis.

Regulatory Compliance

The disclosure was made in compliance with SEBI regulations and the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. No governmental or regulatory approvals were required for this transaction, and no cash consideration or share swap was involved from the parent company's perspective.

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
+0.18%+0.60%+3.69%-16.68%-3.64%+131.11%

What strategic initiatives is Trident Mediquip planning that required this private placement funding, and how might they impact future revenue growth?

Will the new shareholders in Trident Mediquip bring industry expertise or partnerships that could help reverse the declining turnover trend from 2022-23 levels?

How might this dilution affect Trident Lifeline's dividend income from its subsidiary and overall consolidated financial performance?

Trident Lifeline Limited Submits SEBI Compliance Certificate for FY26

1 min read     Updated on 09 Apr 2026, 02:48 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Trident Lifeline Limited has submitted its SEBI compliance certificate under Regulation 74(5) for the year ended March 31, 2026. The certificate, issued by registrar MUFG Intime India Private Limited, confirms proper dematerialisation processes and adherence to prescribed timelines. The submission demonstrates the company's commitment to regulatory compliance and transparent securities management practices.

powered bylight_fuzz_icon
37228700

*this image is generated using AI for illustrative purposes only.

Trident Lifeline Limited has submitted its mandatory compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the period ended March 31, 2026, and confirms the company's adherence to prescribed dematerialisation processes.

Regulatory Compliance Submission

The company submitted the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 on April 08, 2026. The submission was made by Company Secretary and Compliance Officer Nikita Sharma, who holds membership number A60595.

Parameter: Details
Submission Date: April 08, 2026
Reporting Period: Year ended March 31, 2026
Stock Exchange: BSE Limited
Stock ID: TLL
Scrip Code: 543616

Registrar and Transfer Agent Confirmation

MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, serves as the company's registrar and share transfer agent. The firm issued the compliance certificate dated April 01, 2026, confirming proper handling of securities during the quarter ended March 31, 2026.

The certificate confirms that securities received from depository participants for dematerialisation were properly processed within prescribed timelines. MUFG Intime verified that security certificates received for dematerialisation were confirmed or rejected appropriately, with physical certificates mutilated and cancelled after due verification.

Corporate Information

Trident Lifeline Limited, formerly Trident Lifeline Private Limited, operates with CIN number L51909GJ2014PLC078227. The company maintains its registered office at 2004, 2nd Floor, North Extension, Falsawadi, Ring Road, Surat-395003, Gujarat, with manufacturing facilities located at Plot No. 4240, Road No. 42, Sachin GIDC, Surat, Gujarat.

Compliance Framework

The SEBI regulation requires companies to maintain proper records of dematerialisation processes and ensure securities are handled according to prescribed guidelines. The certificate submission demonstrates the company's commitment to regulatory compliance and transparent securities management practices.

MUFG Intime India Private Limited confirmed that depositories' names were substituted in the register of members as registered owners within prescribed timelines, ensuring proper maintenance of shareholder records and compliance with regulatory requirements.

Historical Stock Returns for Trident Lifeline

1 Day5 Days1 Month6 Months1 Year5 Years
+0.18%+0.60%+3.69%-16.68%-3.64%+131.11%

Will Trident Lifeline's consistent regulatory compliance improve its ESG ratings and attract institutional investors in 2026?

How might MUFG Intime's enhanced digital infrastructure impact dematerialization processing times for mid-cap companies like Trident Lifeline?

Could Trident Lifeline's manufacturing expansion in Sachin GIDC lead to increased share issuances requiring additional compliance frameworks?

More News on Trident Lifeline

1 Year Returns:-3.64%